Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.50 USD
Change Today -1.02 / -6.57%
Volume 1.0M
SGMO On Other Exchanges
SGMO is not on other exchanges.
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

H. Ward Wolff

Chief Financial Officer, Principal Accounting Officer and Executive Vice President, Sangamo Biosciences Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. H. Ward Wolff has been an Executive Vice President and the Chief Financial Officer of Sangamo Biosciences Inc., since December 2007 and serves as its Principal Accounting Officer. Mr. Wolff oversees Sangamo's administrative, financial and business development activities and operations. He has over 25 years of financial experience. Mr. Wolff served as Chief Financial Officer and Senior Vice President of Finance of Abgenix Inc. from September 13, 2004 to April 2006 ...

Read Full Background

Corporate Headquarters*

501 Canal Boulevard
Richmond, California 94804

United States

Phone: 510-970-6000
Fax: 510-236-8951

Board Members Memberships*

Chief Financial Officer, Principal Accounting Officer and Executive Vice President
Independent Director and Chairman of Audit Committee
Former Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Director and Chairman of Audit Committee


Harvard Business School
University of California Berkeley

Other Affiliations*

Annual Compensation*

Total Annual Compensation$400,000

Stock Options*

Restricted Stock Awards$424,200
Exercised Options88,000
Exercised Options Value$626,980
Exercisable Options907,000
Exercisable Options Value$5,407,555
Unexercisable Options175,000
Unexercisable Options Value$1,003,425
Total Value of Options$7,037,960
Total Number of Options1,170,000

Total Compensation*

Total Annual Cash Compensation$600,000
Total Short Term Compensation$400,000
Other Long Term Compensation$424,200
Total Calculated Compensation$1,623,078
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGMO:US $14.50 USD -1.02


Nick Leschly Chief Executive Officer, President and Director
bluebird bio, Inc.
David M. Pernock Chairman of the Board, Chief Executive Officer and President
Fibrocell Science, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANGAMO BIOSCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at